Tenders Are Invited For Atropine acquisition, sulfate 1 5 ml (FR) and others (process: 25410012010202120)

1 Atropine sulfatoateatropin sulfate, dosage 10 mgml, use ophthalmic solution Differentiated: Type I exclusive participation of MEEPPEquipped Applicaility Decree 7174: Non application margin Preference: Non QUANTITY: 387Unity: vial 500 ml2 cyclosporincyclosporine, Concentration 05 mgml, pharmaceutical form Emulsion Ophthamic Treatment Differential Treatment: Applicaility Decree 7174: Non Applicaility Preference Margin: Non Quantity: 8000 Supply Unit: Flacone 040 ml3 Ciprofloxacin Chloridropofloxacin Hydrochloride, active ingredient associated with dexamethathone, dosage3 mg 1 mgg, pharmaceutical form ophthalmic ointment Differentiated Treatment: Applicaility Decree 7174: Non applicaility Preference Margin: Non QUANTITY: 300Unity of Supply: Gamling 350 G4 Dexamethasonexamethasone, Dosage 01, presentation Ophthalmic Treatment: Non applicaility pref margin Price: Non Quantity: 828Unity Supply: ottle 500 ML5 Phenylephrine Chlori Penilephrin Hydrochloride, Concentration 10, Indication Ophthalmic Solution Differentiated: Applicaility Decree 7174: Non Applicaility Preference Margin: Non Quantity: 335Unity Supply: ottle 500 ml